“SAFETY SIGNALS FOR HYPERKALEMIA IN TYPE 2 DIABETES: A FOCUSED REVIEW OF SGLT-2, GLP-1, AND DPP-4 DRUG CLASSES”, JMHSR, vol. 2, no. 3, pp. 3711–3716, Jul. 2025, doi: 10.62019/sw57nf20.